KLP Kapitalforvaltning AS lessened its position in Avantor, Inc. (NYSE:AVTR – Free Report) by 41.9% during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 142,200 shares of the company’s stock after selling 102,500 shares during the quarter. KLP Kapitalforvaltning AS’s holdings in Avantor were worth $1,775,000 as of its most recent filing with the SEC.
Other institutional investors have also made changes to their positions in the company. Dodge & Cox grew its position in Avantor by 17.1% in the second quarter. Dodge & Cox now owns 117,433,484 shares of the company’s stock valued at $1,580,655,000 after purchasing an additional 17,170,761 shares in the last quarter. Norges Bank bought a new stake in shares of Avantor in the 2nd quarter valued at about $108,167,000. Engine Capital Management LP acquired a new stake in shares of Avantor in the second quarter valued at approximately $74,088,000. Clarkston Capital Partners LLC lifted its holdings in Avantor by 45.8% during the 2nd quarter. Clarkston Capital Partners LLC now owns 13,982,090 shares of the company’s stock valued at $188,199,000 after purchasing an additional 4,390,140 shares during the last quarter. Finally, Invesco Ltd. boosted its holdings in shares of Avantor by 36.5% during the 2nd quarter. Invesco Ltd. now owns 15,933,860 shares of the company’s stock worth $214,470,000 after buying an additional 4,264,449 shares during the period. Institutional investors own 95.08% of the company’s stock.
Avantor Trading Up 2.9%
Shares of AVTR stock opened at $12.41 on Monday. Avantor, Inc. has a fifty-two week low of $10.62 and a fifty-two week high of $23.32. The company has a debt-to-equity ratio of 0.65, a quick ratio of 0.96 and a current ratio of 1.49. The stock has a 50 day simple moving average of $11.44 and a two-hundred day simple moving average of $12.59. The company has a market cap of $8.46 billion, a P/E ratio of -95.43, a PEG ratio of 4.30 and a beta of 0.93.
Insider Buying and Selling at Avantor
In other news, Director Gregory L. Summe bought 100,000 shares of Avantor stock in a transaction dated Thursday, October 30th. The stock was bought at an average cost of $11.25 per share, for a total transaction of $1,125,000.00. Following the purchase, the director directly owned 300,000 shares in the company, valued at approximately $3,375,000. This represents a 50.00% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Sanjeev K. Mehra purchased 350,000 shares of the company’s stock in a transaction that occurred on Friday, December 5th. The shares were purchased at an average cost of $11.09 per share, for a total transaction of $3,881,500.00. Following the completion of the purchase, the director owned 350,000 shares in the company, valued at $3,881,500. This trade represents a ∞ increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders own 1.20% of the company’s stock.
Analyst Upgrades and Downgrades
Several research firms recently commented on AVTR. Zacks Research upgraded shares of Avantor from a “strong sell” rating to a “hold” rating in a research note on Monday, December 29th. Raymond James Financial cut Avantor from an “outperform” rating to a “market perform” rating in a report on Tuesday, November 4th. Evercore ISI set a $12.00 price objective on shares of Avantor and gave the company an “in-line” rating in a research note on Monday, January 5th. Jefferies Financial Group lowered Avantor to an “underperform” rating in a research note on Wednesday, December 17th. Finally, Bank of America cut shares of Avantor from a “buy” rating to a “neutral” rating and set a $13.00 price objective on the stock. in a research note on Monday, December 15th. Three investment analysts have rated the stock with a Buy rating, thirteen have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $13.60.
View Our Latest Stock Analysis on Avantor
About Avantor
Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.
Avantor’s offerings are organized across two primary segments.
Featured Articles
- Five stocks we like better than Avantor
- Wall Street ‘Sleeper Stock’ Could Become #1 Stock of 2026
- Huge robotics rollout underway
- Do not delete, read immediately
- Free: The Crypto Summit That Could Change Your Life
- Trump Planning to Use Public Law 63-43: Prepare Now
Want to see what other hedge funds are holding AVTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Avantor, Inc. (NYSE:AVTR – Free Report).
Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.
